958 related articles for article (PubMed ID: 29171820)
1. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.
Zeiser R; Blazar BR
N Engl J Med; 2017 Nov; 377(22):2167-2179. PubMed ID: 29171820
[No Abstract] [Full Text] [Related]
2. Embracing the age of artificial intelligence: paradigm shifts, opportunities, and challenges in the treatment of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
An ZY; Zhang XH
Sci China Life Sci; 2024 Jun; 67(6):1302-1304. PubMed ID: 38811443
[No Abstract] [Full Text] [Related]
3. Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease.
Socié G; Kean LS; Zeiser R; Blazar BR
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 34101618
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.
Zeiser R; Blazar BR
N Engl J Med; 2017 Dec; 377(26):2565-2579. PubMed ID: 29281578
[No Abstract] [Full Text] [Related]
5. Acute Graft-versus-Host Disease.
Zeiser R; Blazar BR
N Engl J Med; 2018 Feb; 378(6):586. PubMed ID: 29414273
[No Abstract] [Full Text] [Related]
6. Acute Graft-versus-Host Disease.
Rezvani AR
N Engl J Med; 2018 Feb; 378(6):585-586. PubMed ID: 29419277
[No Abstract] [Full Text] [Related]
7. Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials.
Jagasia M; Zeiser R; Arbushites M; Delaite P; Gadbaw B; Bubnoff NV
Immunotherapy; 2018 Apr; 10(5):391-402. PubMed ID: 29316837
[TBL] [Abstract][Full Text] [Related]
8. New and emerging therapies for acute and chronic graft
Hill L; Alousi A; Kebriaei P; Mehta R; Rezvani K; Shpall E
Ther Adv Hematol; 2018 Jan; 9(1):21-46. PubMed ID: 29317998
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-host disease.
Moreno DF; Cid J
Med Clin (Barc); 2019 Jan; 152(1):22-28. PubMed ID: 30309668
[TBL] [Abstract][Full Text] [Related]
10. The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.
Schroeder MA; Choi J; Staser K; DiPersio JF
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1125-1134. PubMed ID: 29289756
[TBL] [Abstract][Full Text] [Related]
11. Review of Graft-Versus-Host Disease.
Ramachandran V; Kolli SS; Strowd LC
Dermatol Clin; 2019 Oct; 37(4):569-582. PubMed ID: 31466596
[TBL] [Abstract][Full Text] [Related]
12. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R; von Bubnoff N; Butler J; Mohty M; Niederwieser D; Or R; Szer J; Wagner EM; Zuckerman T; Mahuzier B; Xu J; Wilke C; Gandhi KK; Socié G;
N Engl J Med; 2020 May; 382(19):1800-1810. PubMed ID: 32320566
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Penack O; Marchetti M; Ruutu T; Aljurf M; Bacigalupo A; Bonifazi F; Ciceri F; Cornelissen J; Malladi R; Duarte RF; Giebel S; Greinix H; Holler E; Lawitschka A; Mielke S; Mohty M; Arat M; Nagler A; Passweg J; Schoemans H; Socié G; Solano C; Vrhovac R; Zeiser R; Kröger N; Basak GW
Lancet Haematol; 2020 Feb; 7(2):e157-e167. PubMed ID: 32004485
[TBL] [Abstract][Full Text] [Related]
14. Advances in understanding the pathogenesis of graft-versus-host disease.
Zeiser R
Br J Haematol; 2019 Dec; 187(5):563-572. PubMed ID: 31588560
[TBL] [Abstract][Full Text] [Related]
15. Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.
Zhang L; Yu J; Wei W
Front Immunol; 2018; 9():1087. PubMed ID: 29868032
[TBL] [Abstract][Full Text] [Related]
16. 1994 Consensus Conference on Acute GVHD Grading.
Przepiorka D; Weisdorf D; Martin P; Klingemann HG; Beatty P; Hows J; Thomas ED
Bone Marrow Transplant; 1995 Jun; 15(6):825-8. PubMed ID: 7581076
[TBL] [Abstract][Full Text] [Related]
17. ECG-Induced Koebner Phenomenon.
Streit E; Vogelgsang LE
N Engl J Med; 2017 Nov; 377(22):2180. PubMed ID: 29171822
[No Abstract] [Full Text] [Related]
18. Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset.
Hülsdünker J; Ottmüller KJ; Neeff HP; Koyama M; Gao Z; Thomas OS; Follo M; Al-Ahmad A; Prinz G; Duquesne S; Dierbach H; Kirschnek S; Lämmermann T; Blaser MJ; Fife BT; Blazar BR; Beilhack A; Hill GR; Häcker G; Zeiser R
Blood; 2018 Apr; 131(16):1858-1869. PubMed ID: 29463561
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for posttransplantation outcomes.
Paczesny S
Blood; 2018 May; 131(20):2193-2204. PubMed ID: 29622549
[TBL] [Abstract][Full Text] [Related]
20. Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation.
Lee C; Haneuse S; Wang HL; Rose S; Spellman SR; Verneris M; Hsu KC; Fleischhauer K; Lee SJ; Abdi R
PLoS One; 2018; 13(1):e0190610. PubMed ID: 29346409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
